Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 8

1.

Correlation of susceptibility to 6-aminonicotinamide and hydrocortisone-induced cleft palate.

Erickson RP, Karolyi IJ, Diehl SR.

Life Sci. 2005 Mar 18;76(18):2071-8. Epub 2005 Jan 28.

PMID:
15826874
2.

RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone.

Abbott BD, Schmid JE, Brown JG, Wood CR, White RD, Buckalew AR, Held GA.

Toxicol Sci. 1999 Jan;47(1):76-85.

PMID:
10048155
3.

Review of the interaction between TCDD and glucocorticoids in embryonic palate.

Abbott BD.

Toxicology. 1995 Dec 28;105(2-3):365-73. Review.

PMID:
8571373
4.

A region of the mouse genome homologous to human chromosome 1q21 affects facial clefting.

Karolyi J, Erickson RP.

J Craniofac Genet Dev Biol. 1993 Jan-Mar;13(1):1-5. Review.

PMID:
8478414
5.
7.

Synergistic interaction of 2,3,7,8,-tetrachlorodibenzo-p-dioxin and hydrocortisone in the induction of cleft palate in mice.

Birnbaum LS, Harris MW, Miller CP, Pratt RM, Lamb JC.

Teratology. 1986 Feb;33(1):29-35.

PMID:
3738807
8.

CLEFT PALATE IN THE MOUSE: A TERATOGENIC INDEX OF GLUCOCORTICOID POTENCY.

PINSKY L, DIGEORGE AM.

Science. 1965 Jan 22;147(3656):402-3.

PMID:
14221487

Supplemental Content

Support Center